Publications by authors named "Jose Maria Cepeda"

Claim this Profile
E
Effectiveness and safety of rivaroxaban in patients with atrial fibrillation and heart failure in clinical practice: an indirect comparison of national and international registries.
Jose Maria Cepeda, Nicolas Manito, Alejandro Recio Mayoral, Iñaki Lekuona, Miguel Castillo Orive

Front Cardiovasc Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study.
Leopoldo Pérez de Isla, Antonio J Vallejo-Vaz, Gerald F Watts, Ovidio Muñiz-Grijalvo, Rodrigo Alonso, José María Cepeda

Lancet Diabetes Endocrinol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for the care of patients with cardiovascular disease in health emergency situations: a call to action.
Carmen Suárez Fernández, Pedro Armario, José María Cepeda, Maria Dolores López Carmona, José Pablo Miramontes González

Curr Med Res Opin· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alirocumab and Coronary Atherosclerosis in Asymptomatic Patients with Familial Hypercholesterolemia: The ARCHITECT Study.
Leopoldo Pérez de Isla, Jose L Díaz-Díaz, Manuel J Romero, Ovidio Muñiz-Grijalvo, Juan D Mediavilla, José María Cepeda

Circulation· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Projected effectiveness of dapagliflozin in heart failure with reduced ejection fraction in clinical practice.
Manuel Montero-Pérez-Barquero, Carlos Escobar-Cervantes, José Carlos Arévalo-Lorido, Alicia Conde-Martel, Prado Salamanca-Bautista, José María Cepeda

Future Cardiol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat.
José Ramón González-Juanatey, Josep Comín-Colet, Domingo Pascual Figal, Antoni Bayes-Genis, Jose Maria Cepeda

Patient Prefer Adherence· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation.
Jose María Mostaza, Carmen Suarez, Jose María Cepeda, Luis Manzano, Demetrio Sánchez

BMC Cardiovasc Disord· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of heart failure with preserved ejection fraction: Results from the RICA Registry.
Joan Carles Trullàs, Juan Ignacio Pérez-Calvo, Alicia Conde-Martel, Pau Llàcer Iborra, Iván Suárez Pedreira, José María Cepeda

Med Clin (Barc)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comorbidities and their implications in patients with and without type 2 diabetes mellitus and heart failure with preserved ejection fraction. Findings from the rica registry.
José Carlos Arévalo-Lorido, Juana Carretero-Gómez, Ricardo Gómez-Huelgas, Pau Llácer, Luis Manzano, José María Cepeda

Int J Clin Pract· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget impact of ferric carboxymaltose treatment in patients with chronic heart failure and iron deficiency in Spain.
Juan F Delgado, Juan Oliva, Álvaro González-Franco, Jose María Cepeda, Jose Ángel García-García

J Med Econ· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute kidney injury is linked to higher mortality in elderly hospitalized patients with non-valvular atrial fibrillation.
Ignacio Novo-Veleiro, Antonio Pose-Reino, Alejandra Gullón, Jesús Díez-Manglano, José-María Cepeda

Aging Clin Exp Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Influence of frailty on anticoagulant prescription and clinical outcomes after 1‑year follow‑up in hospitalised older patients with atrial fibrillation.
Alejandra Gullón, Francesc Formiga, Jesús Díez-Manglano, José María Mostaza, José María Cepeda

Intern Emerg Med· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of frailty on anticoagulant prescription and clinical outcomes after 1-year follow-up in hospitalised older patients with atrial fibrillation.
Alejandra Gullón, Francesc Formiga, Jesús Díez-Manglano, José María Mostaza, José María Cepeda

Intern Emerg Med· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with discontinuing or not starting oral anticoagulant therapy in older hospitalized patients with non-valvular atrial fibrillation.
Jesús Díez-Manglano, José-María Mostaza, Antonio Pose, Francesc Formiga, José-María Cepeda

Geriatr Gerontol Int· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rivaroxaban: searching the integral vascular protection.
Vivencio Barrios, Manuel Almendro-Delia, Lorenzo Facila, Xavier Garcia-Moll, Pilar Mazón, José María Cepeda

Expert Rev Clin Pharmacol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-505-3p controls chemokine receptor up-regulation in macrophages: role in familial hypercholesterolemia.
Rafael Escate, Pedro Mata, Jose Maria Cepeda, Teresa Padreó, Lina Badimon

FASEB J· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-505-3p controls chemokine receptor up-regulation in macrophages: role in familial hypercholesterolemia.
Rafael Escate, Pedro Mata, Jose Maria Cepeda, Teresa Padró, Lina Badimon

FASEB J· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).
Leopoldo Pérez de Isla, Rodrigo Alonso, Nelva Mata, Cristina Fernández-Pérez, Ovidio Muñiz, José María Cepeda

Circulation· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic treatment and characteristics of elderly patients with non-valvular atrial fibrillation hospitalized at Internal Medicine departments. NONAVASC registry.
Alejandra Gullón, Carmen Suárez, Jesús Díez-Manglano, Francesc Formiga, José María Cepeda

Med Clin (Barc)· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis